VivoSeq
Other

Arthroscopy

0

Pipeline Programs

4

Active Trials

1

Companies Involved

Arthroscopy is an early-stage landscape with 0 programs across 1 company. The most active players are Clinique du Sport, Bordeaux Mérignac.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed8 · 53%
Unknown status3 · 20%
Not yet recruiting2 · 13%
Recruiting2 · 13%

Trial Activity

15 trials

PRCT of FICB vs LAI for Hip Arthroscopy
Completed··N/A·NCT02702661·46 enrolled
LIA in Hip Arthroscopy Patients
Completed·UUniversity of Utah·Phase 1·NCT03070054·74 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)